Follow
Jonathan Caulkins
Jonathan Caulkins
Verified email at andrew.cmu.edu
Title
Cited by
Cited by
Year
Drug policy and the public good
T Babor
Oxford University Press, USA, 2010
5922010
Optimal control of nonlinear processes
D Grass, JP Caulkins, G Feichtinger, G Tragler, DA Behrens
Berlino: Springer, 2008
5482008
Marijuana legalization: What everyone needs to know®
JP Caulkins, B Kilmer, MAR Kleiman
Oxford University Press, 2016
4122016
What price data tell us about drug markets
JP Caulkins, P Reuter
Journal of drug issues 28 (3), 593-612, 1998
3801998
Variation in cannabis potency and prices in a newly legal market: evidence from 30 million cannabis sales in Washington state
R Smart, JP Caulkins, B Kilmer, S Davenport, G Midgette
Addiction 112 (12), 2167-2177, 2017
3702017
Drug policy and the public good: evidence for effective interventions
J Strang, T Babor, J Caulkins, B Fischer, D Foxcroft, K Humphreys
The Lancet 379 (9810), 71-83, 2012
3502012
Public health implications of legalising the production and sale of cannabis for medicinal and recreational use
W Hall, D Stjepanović, J Caulkins, M Lynskey, J Leung, G Campbell, ...
The Lancet 394 (10208), 1580-1590, 2019
3162019
Developing public health regulations for marijuana: lessons from alcohol and tobacco
RL Pacula, B Kilmer, AC Wagenaar, FJ Chaloupka, JP Caulkins
American journal of public health 104 (6), 1021-1028, 2014
3132014
Mandatory minimum drug sentences: throwing away the key or the taxpayers' money?
JP Caulkins, CP Rydell, WL Schwabe, J Chiesa
RAND-PUBLICATIONS-MR-ALL SERIES-, 1997
2481997
Considering marijuana legalization: Insights for Vermont and other jurisdictions
JP Caulkins, B Kilmer, M Kleiman, RJ MacCoun, G Midgette, P Oglesby, ...
Rand Corporation, 2015
237*2015
Responding to the opioid crisis in North America and beyond: recommendations of the Stanford–Lancet Commission
K Humphreys, CL Shover, CM Andrews, ASB Bohnert, ML Brandeau, ...
The Lancet 399 (10324), 555-604, 2022
2322022
Altered state?: assessing how marijuana legalization in California could influence marijuana consumption and public budgets
B Kilmer, JP Caulkins, RL Pacula, RJ MacCoun, P Reuter
RAND, 2010
2032010
How drug enforcement affects drug prices
JP Caulkins, P Reuter
Crime and Justice 39 (1), 213-271, 2010
2002010
Marijuana markets: Inferences from reports by the household population
JP Caulkins, RL Pacula
Journal of Drug Issues 36 (1), 173-200, 2006
1972006
Three strikes and you’re out: Estimated benefits and costs of California’s new mandatory-sentencing law
PW Greenwood, CP Rydell, AF Abrahamse, JP Caulkins, J Chiesa, ...
Santa Monica, CA: Rand, 1994
1801994
Research note—Sell first, fix later: Impact of patching on software quality
A Arora, JP Caulkins, R Telang
Management Science 52 (3), 465-471, 2006
1772006
Drugs and drug policy: What everyone needs to know®
MAR Kleiman, JP Caulkins, A Hawken
Oxford University Press, 2011
1702011
Enforcement or treatment? Modeling the relative efficacy of alternatives for controlling cocaine
CP Rydell, JP Caulkins, SS Everingham
Operations Research 44 (5), 687-695, 1996
1681996
Price and purity analysis for illicit drug: Data and conceptual issues
JP Caulkins
Drug and alcohol dependence 90, S61-S68, 2007
1642007
A dynamic model of drug initiation: implications for treatment and drug control
DA Behrens, JP Caulkins, G Tragler, JL Haunschmied, G Feichtinger
Mathematical Biosciences 159 (1), 1-20, 1999
1541999
The system can't perform the operation now. Try again later.
Articles 1–20